Mechanism of follicular trapping: localization of immune complexes and cell remnants after elimination and repopulation of different spleen cell populations.

Por Laman, J D, Kors, N, Van Rooijen, N, Claassen, E
Publicado em 1990

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

Por Gerritse, K, Laman, J D, Noelle, R J, Aruffo, A, Ledbetter, J A, Boersma, W J, Claassen, E
Publicado em 1996

Pro-inflammatory cytokines in cryptoglandular anal fistulas

Por van Onkelen, R. S., Gosselink, M. P., van Meurs, M., Melief, M. J., Schouten, W. R., Laman, J. D.
Publicado no Tech Coloproctol (2016)

Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis

Por Branton, W. G., Lu, J. Q., Surette, M. G., Holt, R. A., Lind, J., Laman, J. D., Power, C.
Publicado no Sci Rep (2016)

Ganglioside Mimicry of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity in Rabbits

Por Ang, C. W., Noordzij, P. G., de Klerk, M. A., Endtz, H. P., van Doorn, P. A., Laman, J. D.
Publicado em 2002

Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.

Por Green, K A, Crassi, K M, Laman, J D, Schoneveld, A, Strawbridge, R R, Foy, T M, Noelle, R J, Green, W R
Publicado em 1996

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable d...

Por Laman, J D, Schellekens, M M, Abacioglu, Y H, Lewis, G K, Tersmette, M, Fouchier, R A, Langedijk, J P, Claassen, E, Boersma, W J
Publicado em 1992

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable d...

Por Laman, J D, Schellekens, M M, Abacioglu, Y H, Lewis, G K, Tersmette, M, Fouchier, R A, Langedijk, J P, Claasen, E, Boersma, W J
Publicado em 1992

Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients

Por Schrijver, I A, De Man, Y A, Melief, M -J, Van Laar, J M, Markusse, H M, Klasen, I S, Hazenberg, M P, Laman, J D
Publicado em 2001

Guillain-Barré Syndrome- and Miller Fisher Syndrome-Associated Campylobacter jejuni Lipopolysaccharides Induce Anti-GM(1) and Anti-GQ(1b) Antibodies in Rabbits

Por Ang, C. W., De Klerk, M. A., Endtz, H. P., Jacobs, B. C., Laman, J. D., van der Meché, F. G. A., van Doorn, P. A.
Publicado em 2001

Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.

Por Vyth-Dreese, F A, Boot, H, Dellemijn, T A, Majoor, D M, Oomen, L C, Laman, J D, Van Meurs, M, De Weger, R A, De Jong, D
Publicado em 1998

Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients

Por Ang, C. W., Laman, J. D., Willison, H. J., Wagner, E. R., Endtz, H. P., De Klerk, M. A., Tio-Gillen, A. P., Van den Braak, N., Jacobs, B. C., Doorn, P. A. Van
Publicado em 2002